Roivant Sciences Ltd. (ROIV)
$35.44+3.60%Close
SELLBEAR · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $25.6B
- Beta
- 1.12
- P/E (TTM)
- -93.50
- Short % float
- 6.81%
- Days to cover
- 4.4
- SI change
- +8.6%
- 1W
- -0.78%
- 1M
- -13.43%
- vs SPY 1W
- -1.94%
- vs SPY 1M
- -16.43%
Industry peers
FMP comparable companies · ranked by market cap
- VRTXSELLVertex Pharmaceuticals Incorporated$129.5BBEARQ 23$510.08+1.36%
- MRNABUYModerna, Inc.$89.3BRECOVERYQ 36$225.00+14.21%
- REGNSELLRegeneron Pharmaceuticals, Inc.$76.9BBEARQ 24$746.54+0.94%
- BIIBBUYBiogen Inc.$33.3BBULLQ 19$225.71+3.33%
- ALNYSELLAlnylam Pharmaceuticals, Inc.$31.1BRECOVERYQ 28$232.68+3.63%
- BNTXSELLBioNTech SE$24.4BRECOVERYQ 35$96.96+5.32%
- UTHRBUYUnited Therapeutics Corporation$23.3BRECOVERYQ 20$549.16+3.07%
- INCYSELLIncyte Corporation$22.9BBEARQ 13$112.79+0.04%
- GMABBUYGenmab A/S$22.8BBULLQ 21$37.07+2.83%
- JAZZSELLJazz Pharmaceuticals plc$13.7BBEARQ 24$218.42-1.81%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
